The European Bank for Reconstruction and Development (EBRD) has provided JSC Farmak (Kyiv) with a loan of EUR 20 million to replenish working capital, according to a press release from the EBRD.
"The EBRD is lending EUR 20 million to a leading Ukrainian pharmaceuticals manufacturer, JSC Farmak, under its EUR 2 billion Resilience and Livelihoods Framework supporting countries affected by the war in Ukraine," the report says.
The program provides for the sustainability and preservation of livelihoods and support for countries affected by the war in Ukraine.
According to the EBRD, the total amount of the Program is EUR 2 billion.
The EBRD reports that this loan has a 5.5% first loss guarantee under the EBRD's Shareholder Special Fund Risk Sharing Programme. Thus, the total donor guarantee will cover 50% of the loan amount.
Advertising
Advertising
MORE ABOUT
Zelenskyy discusses support for Ukrainians with EBRD president
18:59, 06.02.2025
Ukrnafta and EBRD plan to build modern combined-cycle CHPP
16:44, 06.02.2025
Ukrainian PM, EBRD President discuss strengthening cooperation in energy, infrastructure
20:04, 04.02.2025
Ukraine discusses establishing consolidated capital market institution under EBRD auspices – regulator
16:52, 04.02.2025
EBRD starts procurement of gas power plants under agreements with Ukrnafta
16:44, 30.12.2024
LATEST
Joint U.S.-Ukraine Fund to be replenished through new projects via state budget – Minister of Economy
10:11, 27.02.2025
Biosphere Corporation plans to increase revenue by 20% in 2025
20:53, 26.02.2025
Ukraine's National Bank denies granting approval for the acquisition of BTA Bank
19:43, 26.02.2025
DTEK plans to announce new deals to supply LNG to Ukraine in coming months
19:21, 26.02.2025
Ukraine exports almost 3 mln tonnes of grain in Feb - Agrarian Ministry